FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

387047007: Loteprednol etabonate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1763813019 Loteprednol etabonate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1776051014 Loteprednol etabonate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3114191000052115 loteprednoletabonat sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Loteprednol etabonate (substance) Is a Adrenal cortex hormone false Inferred relationship Some
Loteprednol etabonate (substance) Is a Glucocorticoid hormone false Inferred relationship Some
Loteprednol etabonate (substance) Is a Loteprednol (substance) false Inferred relationship Some
Loteprednol etabonate (substance) Is modification of (attribute) Loteprednol (substance) true Inferred relationship Some
Loteprednol etabonate (substance) Is a syntetisk glukokortikoid false Inferred relationship Some
Loteprednol etabonate (substance) Has disposition (attribute) Androgen receptor agonist (disposition) false Inferred relationship Some
Loteprednol etabonate (substance) Has disposition (attribute) könskörtelhormon false Inferred relationship Some
Loteprednol etabonate (substance) Is a Androstane true Inferred relationship Some
Loteprednol etabonate (substance) Is a Glucocorticoid (substance) true Inferred relationship Some
Loteprednol etabonate (substance) Is a Antilipemic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
loteprednoletabonat för oftalmiskt bruk Has active ingredient False Loteprednol etabonate (substance) Inferred relationship Some
Loteprednol etabonate 5 mg/mL eye suspension Has active ingredient False Loteprednol etabonate (substance) Inferred relationship Some
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has active ingredient False Loteprednol etabonate (substance) Inferred relationship Some
loteprednoletabonat Has active ingredient False Loteprednol etabonate (substance) Inferred relationship Some
loteprednoletabonat + tobramycin Has active ingredient False Loteprednol etabonate (substance) Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has active ingredient False Loteprednol etabonate (substance) Inferred relationship Some
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has precise active ingredient True Loteprednol etabonate (substance) Inferred relationship Some 1
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has basis of strength substance (attribute) True Loteprednol etabonate (substance) Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL eye suspension Has basis of strength substance (attribute) True Loteprednol etabonate (substance) Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL eye suspension Has precise active ingredient True Loteprednol etabonate (substance) Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has precise active ingredient True Loteprednol etabonate (substance) Inferred relationship Some 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has basis of strength substance (attribute) True Loteprednol etabonate (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start